Direct Targeting of RET Aberrations Moves Closer to the Clinic - OncLive

Direct Targeting of RET Aberrations Moves Closer to the Clinic  OncLive

Over the past 30 years, from the discovery of a fusion rearrangement to the recent promise of LOXO-292, RET targeting has gone from distant concept toward ...

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2L7pDw9